July 26, 2024
A cure worse than the disease? The controversy on Twitter around a fake COVID-19 treatment from France
This paper combines network analysis and the text analysis of 1.2 million tweets to examine the Twitter controversy around Didier Raoult’s proposal of a new therapy against COVID-19. It finds that media events drove spikes in Twitter activity, while pro-Raoult networks connected French-speaking groups with Trump and Bolsonaro supporters and blended conspiracy narratives with critiques of liberal political economy.
Abstract
This paper analyzes both the network of actors and the network of the discourses mobilized in the controversy around Professor Didier Raoult and his Hydroxychloroquine-based therapeutic proposal against COVID-19. To confirm our hypothesis, we implement a sophisticated and innovative research method on a corpus of 1.2 million Tweets, which consists of applying a network analysis combined with a lexicometrics analysis. We show that the reaction peaks on Twitter were linked to important media events. Moreover, many groups clustered around the accounts of political figures and media outlets that received numerous mentions. Trump's and Bolsonaro's supporter groups also connected with the French-speaking pro-Raoult groups. The messages of the pro-Raoult combined anti-science conspiracy theories and a critique of the political economy of liberalism and its impasses.
To continue reading please visit: https://doi.org/10.12681/grsr.38490
This open access article was published in the Greek Review of Social Research on 26 July 2024.
Smyrnaios, N., Tsimpoukis, P., & Papaevangelou, C. (2024). A cure worse than the disease? The controversy on Twitter around a fake COVID-19 treatment from France . The Greek Review of Social Research, 163, 11–36. https://doi.org/10.12681/grsr.38490
Keywords: Controversy, Covid-19, Twitter, Discourse, Network Analysis, Iramuteq
More results /
AI insiders warn it could end humanity. Does the public agree?
By Ernesto de León • Claes de Vreese • September 17, 2026
By Natali Helberger • June 16, 2026
By José van Dijck • April 30, 2026
Loss of judicial sight? The impact of assistive AI technologies on judicial perception — beyond the question of discretion
By Iris van Domselaar • Isabella Banks • September 23, 2026
By Tynke Schepers • July 09, 2026
By Corinne Cath • May 29, 2026
Fairy Tales That Make Life Harder: AI, and the social and ethical costs of believing in it
By Martijn Logtenberg • September 28, 2026
By Martijn Logtenberg • March 13, 2026
By Martijn Logtenberg • November 20, 2025
The Label Paradox: Can AI transparency create more distrust?
By Natali Helberger • September 21, 2026
By Jin Wan • Theo Araujo • Natali Helberger • Claes de Vreese • September 17, 2026
By João Pedro Quintais • September 03, 2026